Physician profile
Gregory Mark Singer
NPI 1114010865
$84,842.40
in general payments reported to CMS, 2019-2025
10 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $14K · 2021: $22K · 2022: $18K · 2023: $1,213 · 2024: $93.97 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,001 · Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.50 |
| Food and Beverage | $561.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $62,856.40 | 2019-2023 | Xarelto |
| Amgen INC. | $18,965.43 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $1,190.16 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $713.32 | 2019-2024 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $462.56 | 2019-2023 | |
| Medtronic, INC. | $282.09 | 2021-2025 | In.Pact Admiral, Aurora Ev-Icd Mri Surescan, Linq II |
| Abbott Laboratories | $166.13 | 2019 | |
| Welch Allyn | $162.00 | 2021 | |
| Medtronic Vascular, INC. | $31.73 | 2019-2020 | |
| Pfizer INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.